Withheld: Real-World Infant Deaths from RSV Antibody Shot
It is no longer tenable for either product to remain shielded from full scrutiny. Both nirsevimab (Beyfortus) and clesrovimab warrant a thorough re-evaluation by ACIP – this time with complete data on the table.
Withheld: Real-World Infant Deaths from RSV Antibody Shot Read Journal Article











